Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnab Basu

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Current Microbiology|October 31, 2025
Nitroxoline Shows Synergy with Colistin Potentiating its Bactericidal Efficacy in Opportunist Pathogen Pseudomonas aeruginosaDebasrita RoyChowdhury, Soumyananda Chakraborti, Sukhendu Mandal, et al.
Virology|March 21, 2006
Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytesArnab Basu, Keith Meyer, Keith K Lai, et al.
Journal of Medical Microbiology|January 27, 1999
Response of wild-type mutants of Vibrio cholerae O1 possessing different combinations of virulence genes in the ligated rabbit ileal loop and in Ussing chambers: evidence for the presence of additional secretogenHemanta Koley, Rupak Mitra, Arnab Basu, et al.
JCO Precision Oncology|June 11, 2025
Utility of Tumor-Informed Circulating Tumor DNA for Monitoring Treatment Response in Nonmetastatic, Locally Advanced Penile and Primary Urethral CancersKartik R Patel, Sol C Moon, Luke A Shumaker, et al.
Frontiers in Cellular and Infection Microbiology|January 2, 2025
Amoebae: beyond pathogens- exploring their benefits and future potentialSuman Kalyan Dinda, Shreyasee Hazra, Anwesha De, et al.
ACS Infectious Diseases|March 18, 2017
Molecular Mechanism Underlying the Action of Influenza A Virus Fusion Inhibitor MBX2546Arnab Basu, Gloria Komazin-Meredith, Courtney McCarthy, et al.
Plos One|October 26, 2018
Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patientsMonica Khunger, Pradnya Dinkar Patil, Arjun Khunger, et al.
The Oncologist|August 19, 2025
HER2 Alterations across Solid Tumors: Implications for Comprehensive TestingAhmed Ismail, Chimay Jani, Nusrat Jahan, et al.
Frontiers in Oncology|November 16, 2020
Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional CohortPedro Barata, Whitley Hatton, Arpita Desai, et al.
The Journal of Infectious Diseases|July 25, 2015
Novel Small Molecule Entry Inhibitors of Ebola VirusArnab Basu, Debra M Mills, Daniel Mitchell, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Current Microbiology|October 31, 2025
Nitroxoline Shows Synergy with Colistin Potentiating its Bactericidal Efficacy in Opportunist Pathogen Pseudomonas aeruginosaDebasrita RoyChowdhury, Soumyananda Chakraborti, Sukhendu Mandal, et al.
Virology|March 21, 2006
Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytesArnab Basu, Keith Meyer, Keith K Lai, et al.
Journal of Medical Microbiology|January 27, 1999
Response of wild-type mutants of Vibrio cholerae O1 possessing different combinations of virulence genes in the ligated rabbit ileal loop and in Ussing chambers: evidence for the presence of additional secretogenHemanta Koley, Rupak Mitra, Arnab Basu, et al.
JCO Precision Oncology|June 11, 2025
Utility of Tumor-Informed Circulating Tumor DNA for Monitoring Treatment Response in Nonmetastatic, Locally Advanced Penile and Primary Urethral CancersKartik R Patel, Sol C Moon, Luke A Shumaker, et al.
Frontiers in Cellular and Infection Microbiology|January 2, 2025
Amoebae: beyond pathogens- exploring their benefits and future potentialSuman Kalyan Dinda, Shreyasee Hazra, Anwesha De, et al.
ACS Infectious Diseases|March 18, 2017
Molecular Mechanism Underlying the Action of Influenza A Virus Fusion Inhibitor MBX2546Arnab Basu, Gloria Komazin-Meredith, Courtney McCarthy, et al.
Plos One|October 26, 2018
Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patientsMonica Khunger, Pradnya Dinkar Patil, Arjun Khunger, et al.
The Oncologist|August 19, 2025
HER2 Alterations across Solid Tumors: Implications for Comprehensive TestingAhmed Ismail, Chimay Jani, Nusrat Jahan, et al.
Frontiers in Oncology|November 16, 2020
Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional CohortPedro Barata, Whitley Hatton, Arpita Desai, et al.
The Journal of Infectious Diseases|July 25, 2015
Novel Small Molecule Entry Inhibitors of Ebola VirusArnab Basu, Debra M Mills, Daniel Mitchell, et al.
Pageof 9